Literature DB >> 31055565

Successful Treatment of Severe Hyperammonaemia with Ultra-High Dose Continuous Veno-Venous Haemodiafiltration.

Dirk P Boer1, Sarah L Mourik2, Martijn W F van den Hoogen3, Janneke G Langendonk4, Hilde R H de Geus5.   

Abstract

Hyperammonaemia is a severe condition and often requires a multimodal treatment regimen. Dialysis has been described as a potential treatment option, but currently it is not the standard of care. In this report, we describe a case of a 40-year-old postpartum woman who developed severe hyperammonaemia due to liver failure and acute kidney injury (AKI) combined with a large intra-abdominal haematoma producing nitrogen waste products. She was treated successfully with continuous veno-venous haemodiafiltration using an ultra-high effluent rate (100 mL/kg/h) and was discharged alive 32 days after the initial admission. Our report indicates that successful ammonia clearance in the setting of AKI can be obtained only by using this high effluent rate. This treatment modality should be considered in all patients with AKI and severe hyperammonaemia when other treatment modalities fail to lower ammonia levels within hours to prevent irreversible but preventable neurological damage.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Continuous veno-venous haemodiafiltration; Hyperammonaemia; Renal replacement therapy

Mesh:

Year:  2019        PMID: 31055565      PMCID: PMC7114906          DOI: 10.1159/000499829

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  3 in total

Review 1.  The Role of RRT in Hyperammonemic Patients.

Authors:  Shruti Gupta; Andrew Z Fenves; Robert Hootkins
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

2.  Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure.

Authors:  Filipe S Cardoso; Michelle Gottfried; Shannan Tujios; Jody C Olson; Constantine J Karvellas
Journal:  Hepatology       Date:  2017-12-26       Impact factor: 17.425

3.  Ammonia clearance with haemofiltration in adults with liver disease.

Authors:  Andrew J Slack; Georg Auzinger; Chris Willars; Tracy Dew; Rebecca Musto; Daniel Corsilli; Roy Sherwood; Julia A Wendon; William Bernal
Journal:  Liver Int       Date:  2013-06-20       Impact factor: 5.828

  3 in total
  1 in total

1.  Kinetics of Bilirubin and Ammonia Elimination during Hemadsorption Therapy in Secondary Sclerosing Cholangitis Following ECMO Therapy and Severe COVID-19.

Authors:  Désirée Tampe; Peter Korsten; Sebastian C B Bremer; Martin S Winkler; Björn Tampe
Journal:  Biomedicines       Date:  2021-12-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.